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γδ T cells form an abundant part of the human cellular immune
system, where they respond to tissue damage, infection, and can-
cer. The spectrum of known molecular targets recognized by Vδ1-
expressing γδ T cells is becoming increasingly diverse. Here we
describe human γδ T cells that recognize CD1b, a lipid antigen-
presenting molecule, which is inducibly expressed on monocytes
and dendritic cells. Using CD1b tetramers to study multiple donors,
we found that many CD1b-specific γδ T cells use Vδ1. Despite their
common use of Vδ1, three CD1b-specific γδ T cell receptors (TCRs)
showed clear differences in the surface of CD1b recognized, the
requirement for lipid antigens, and corecognition of butryophilin-
like proteins. Several Vγ segments were present among the CD1b-
specific TCRs, but chain swap experiments demonstrated that CD1b
specificity was mediated by the Vδ1 chain. One of the CD1b-specific
Vδ1+ TCRs paired with Vγ4 and shows dual reactivity to CD1b and
butyrophilin-like proteins. αβ TCRs typically recognize the peptide
display platform of MHC proteins. In contrast, our results demon-
strate the use of rearranged receptors to mediate diverse modes of
recognition across the surface of CD1b in ways that do and do not
require carried lipids.
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In all species with T cells, two major lineages can be distinguishedbased on T cell receptor (TCR) gene usage, αβ T cells and γδ
T cells. In humans, the γδ T cell population comprises ∼4% of
circulating T cells (1), of which the Vδ1- and Vδ2-expressing subsets
are the two most abundant. Semi-invariant Vγ9Vδ2 T cells form the
most prominent γδ T cell population found in the circulation, while
the highly diverse Vδ1 T cells form the majority in tissues, such as
intestine and spleen (2, 3).
The mechanism of antigen recognition by αβ T cells has been
well established to involve TCR contact with the membrane distal
surface of MHC I and II, where peptide antigens are exposed (4).
Much less is known about the identities and nature of molecular
targets of γδ T cells. γδ TCRs have been implicated in sensing
molecular signals of microbial and nonmicrobial stress via recog-
nition of cellular proteins, soluble proteins, or small molecules,
suggesting a role for these cells in stress surveillance. The Vγ9Vδ2
population is stimulated by small phosphorylated metabolites in a
butyrophilin (BTN) 2A1-, BTN3A1-, and BTN3A2-dependent way
(5–7). Colonic Vγ4+ T cells respond to gut epithelial cells by
binding to butyrophilin-like (BTNL) 3 and BTNL8 heterodimers
through the Vγ4 chain (8–10). Human Vδ1 T cells recognize an
array of proteins, including annexin A2, phycoerythrin, MR1, CD1c,
and CD1d proteins (11–21). Knowing how αβ T cells depend on a
large number of highly diverse V(D)J joints to recognize almost
every imaginable peptide bound to major histocompatibility com-
plex (MHC) proteins, it seems counterintuitive that γδ T cells would
use the same diversity-generating mechanisms to generate millions
of unique TCRs for recognition of only a handful of nonpolymorphic
targets that do not present an antigen.
The CD1 family of proteins (CD1a, CD1b, CD1c, and CD1d)
consists of nonpolymorphic MHC class I–like molecules encoded
outside the MHC that present self- and pathogen-derived lipid anti-
gens to T cells. CD1d is constitutively expressed on both hema-
topoietic and nonhematopoietic cells, while CD1a and CD1c are
expressed by professional antigen-presenting cells (APCs), such as
Langerhans cells (CD1a), B cells (CD1c), and dendritic cells (CD1a
and CD1c) (22). Expression of CD1b in the periphery is limited to
mature dendritic cells (DCs). However, CD1a, CD1b, and CD1c
expression can rapidly be up-regulated on monocytes in response to
cytokines (23–26). The first study describing the interaction of CD1
molecules with γδ T cells showed that Vδ1 TCRs are activated by
CD1c in the absence of a foreign antigen (16). The development of
CD1 tetramers has enabled the detection of γδ T cells from human
peripheral blood that recognize CD1c (18, 21). In addition to CD1c,
CD1d-reactive γδ T cells have also been described to recognize CD1d
presenting the self-lipid sulfatide or α-galactosylceramide (17, 19, 20).
Most known CD1-specific γδ T cells express Vδ1. The biased
use of Vδ1 by CD1c- and CD1d-specific γδ TCRs suggests that
there could be a conserved docking mode for the interaction
between Vδ1 and CD1 isoforms. Mutational analysis and crystal
structures of CD1-specific γδ TCRs demonstrate a dominant role
for the Vδ1 chain in binding of CD1c and CD1d, while the γ chain
was either minimally involved or not involved at all (18–20). The
recent discoveries that γδ TCRs interact with BTNs and BTNLs
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and that the interaction is mediated by the Vγ domain (5, 9, 10)
point to γδ TCRs as potentially bispecific receptors and are con-
sistent with Vδ1-dominated CD1 recognition.
The importance and function of CD1 recognition by γδ T cells
is not well understood. Recognition of endogenous self-lipids
might be of importance under conditions of cell stress, such as
infections, cancer, and cell damage (27). γδ TCRs might sense
stress through recognition of CD1 proteins that are up-regulated
upon inflammatory signals and combine this with conserved
binding of BTNs or BTNLs to recognize self. On the other hand,
CD1 is well known to present bacterial glycolipids such as glu-
cose monomycolate, mycolic acid, dideoxymycobactin, sulfogly-
colipid, and mannosyl phosphomycoketide to αβ T cells, which is
reminiscent of the presentation of pathogen-derived peptides by
classical MHC molecules, the cornerstone of adaptive immunity.
The previous findings on γδ T cells that recognize CD1c and
CD1d led us to the question of whether γδ T cells that recognize
other CD1 molecules also exist. CD1b is, in this respect, particularly
interesting because it is known to present bacterial as well as self-
antigens to αβ T cells via mechanisms that are understood in great
molecular detail (28–31). In addition, CD1b is the most stress reg-
ulated CD1 isoform in the sense that no human tissue other than the
thymus expresses CD1b under homeostatic conditions, yet it is up-
regulated under inflammatory conditions (23, 32). Therefore, we
decided to specifically look for CD1b-specific γδ T cells and deter-
mine whether they recognize CD1b per se or CD1b–lipid complexes.
Results
Identification of CD1b Tetramer-Reactive γδ T Cells. To determine if
γδ T cells might recognize CD1b, we enriched γδ T cells from
B
A
C
D
Fig. 1. Identification of CD1b-endo-recognizing γδ T cells. (A) Percentages of CD1b-endo tetramer+ γδ T cells of total γδ T cells enriched from PBMCs by
column purification (n = 8 PBMC samples) are shown. Flow cytometry dot plots show CD1b-endo tetramer staining of γδ T cells from three representative
donors (gated as shown in SI Appendix, Fig. S1). (B) Overlaid flow cytometry dot plots of CD1b-endo tetramer+ (blue) and CD1b-endo tetramer− (red) γδ T cell
populations from eight donors (gated as shown in SI Appendix, Fig. S1). Percentages of Vδ1− and Vδ1+ cells are shown separately for the CD1b tetramer+ and
CD1b tetramer− populations. (C) Flow cytometric dot plots of line TS1+ (gated on CD3+ cells) and line TS1−. Four CD1b tetramer-positive populations can be
observed: BC14.1, BC14.2, BC14.3, and BC14.4. (D) Paired TCR sequences of four human CD1b-endo-recognizing γδ TCRs determined using a multiplex PCR and
Sanger sequencing-based approach.
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peripheral blood mononuclear cells (PBMCs) from eight random
blood bank donors by column purification and stained them with
CD1b tetramers. Tetramers were not treated with antigens and
so carried a mixture of endogenous (CD1b-endo) lipids from the
mammalian protein expression system. Low numbers of residual
αβ T cells were excluded by gating on CD3+αβTCR− cells (SI
Appendix, Fig. S1A). CD1b tetramer+ cells were detected in all
donors tested (SI Appendix, Fig. S1B), with frequencies ranging
from 0.011 to 0.088% of total γδ T cells, as illustrated by flow
cytometry dot plots from donor 8, donor 3, and donor 4, rep-
resenting frequencies at the high, intermediate, and low end of
the range (Fig. 1A). Most published γδ TCRs that recognize
other members of the CD1 family, CD1c and CD1d, are Vδ1+ γδ
T cells (17–21), and the majority of Vδ2+ T cells recognizes
targets other than CD1. Therefore, we hypothesized that CD1b-
specific γδ T cells might be of the Vδ1 type. The frequency of
Vδ1-utilizing TCRs among the CD1b tetramer+ γδ T cells was
higher than among tetramer− γδ T cells in seven out of eight
donors, as demonstrated by costaining with an anti-Vδ1 antibody
(Fig. 1B), but Vδ1+ γδ T cells formed the majority of the CD1b-
endo tetramer+ fraction in only four of the eight donors. Thus,
CD1b-binding γδ T cells are present in the blood of healthy
donors, and about half of them express Vδ1+ TCRs.
To discover TCRs and enable functional studies of T cell re-
sponse, we used flow cytometry to sort CD1b tetramer+ T cells
from PBMCs. After two rounds of T cell sorting and expansion,
we obtained an oligoclonal T cell line from a blood bank–derived
buffy coat (BC14) in which ∼3% of the cells stained brightly with
CD1b tetramer (SI Appendix, Fig. S2A). Further sorting based on
the anti-Vδ1 antibody (clone TS1) generated two separate cell
lines: line TS1+ (anti-Vδ1+) and line TS1−, which was CD3+ but
anti-TCR αβ−, anti-Vδ1−, and anti-Vδ2− (SI Appendix, Fig. S2B).
Staining of line TS1+ with CD1b tetramer and anti-Vδ1 antibody
showed three distinct tetramer positive subpopulations, which we
named BC14.1, BC14.2, and BC14.3, while line TS1− contained
one tetramer-positive population called BC14.4 (Fig. 1C). To
fully characterize the CD1b-binding γδ TCR sequences, we bulk
sorted each of the four populations and used a multiplex PCR
approach (Fig. 1D), which resulted in one TCR γ chain and one
TCR δ chain nucleotide sequence for each population, solving
four paired clonal TCRs. All CD1b tetramer-positive pop-
ulations, including the BC14.4 TCR, which did not stain with the
TS1 antibody, expressed Vδ1 TCRs but differed in their CDR3δ
regions. The TCR γ chains were all different and used the Vγ4,
Vγ8, Vγ9, or Vγ3 segments. Thus, we were able to detect CD1b
tetramer-binding γδ T cells ex vivo and derive paired TCR γ and
δ chain sequences of four Vδ1+ γδ T cell clones.
Primary CD1b-Endo-Recognizing γδ T Cells Show Autoreactivity. The
usual ligand for tetramers of antigen-presenting molecules is the
TCR. However, because γδ T cells that are functionally reactive
to CD1b were unknown, we asked whether T cells sorted on
CD1b tetramers could functionally recognize CD1b. Line TS1+
γδ T cells produced interferon γ (IFNγ) when stimulated with the
myelogenous leukemia cell line K562 transfected with CD1b
(K562.CD1b) in the absence of an added foreign lipid but not
when stimulated with K562.CD1a (Fig. 2A). In addition, we
tested down-regulation of the TCR and up-regulation of acti-
vation markers as an outcome of TCR activation. Stimulation of
line TS1+ with K562.CD1b cells but not K562.CD1a cells in-
duced complete down-regulation of the TCR, as seen by loss of
tetramer binding and the appearance of a CD3-low population,
while stimulation with C1R.CD1b showed a partial response
(Fig. 2B). Tetramer+ cells cocultured with C1R.CD1b showed
TCR down-regulation, as evidenced by the lower intensity of
staining for Vδ1 and CD3. T cell activation was apparent based on
CD25 and CD69 up-regulation (Fig. 2C). Thus, primary CD1b
tetramer+ T cells show functional responses to CD1b+ cells, which
is consistent with direct TCR recognition of CD1b.
γδ TCR Recognition of CD1b. To formally test if CD1b was acti-
vating the γδ T cells by binding to the TCRs we sequenced, we
transiently transfected 293T cells with the γδ TCRs and the CD3
complex proteins CD3γ, CD3δ, CD3ζ, and CD3e and stained
them with CD1b-endo tetramers. Each transfection showed TCR
expression on the cell surface as measured by antibodies against
both CD3 and the γδ TCR (SI Appendix, Fig. S3A). Staining of
the transfected 293T cells confirmed binding of CD1b-endo
tetramers by three of the four TCRs (Fig. 2D). BC14.3 did not
bind the CD1b-endo tetramer, which could mean that the TCR
was of low affinity.
Next, we stably transduced Jurkat 76 (J76) cells (a TCR-negative
T cell line, ref. 33) with the confirmed CD1b tetramer-binding
TCRs to generate stable cell lines (called J76.BC14.1, J76.BC14.2,
and J76.BC14.4) for further tetramer assays (SI Appendix, Fig. S3B).
J76 cells normally express CD1b, so to prevent self-activation upon
transduction with CD1b-reactive TCRs, we first deleted CD1b (SI
Appendix, Fig. S3C). The resulting CD1b-negative, TCR-transduced
lines J76.BC14.1, J76.BC14.2, and J76.BC14.4 displayed compara-
ble staining intensity of the CD1b-endo tetramer (Fig. 2 E, Left) but
did not stain with CD1a-, CD1c-, or CD1d-endo tetramers (Fig. 2 E,
Right). When cocultured with C1R.CD1b cells, a fraction of each
line up-regulated the activation marker CD69 (Fig. 2F), consistent
with TCR-dependent signaling observed for the primary γδ T cells.
Even though BC14.1 stained intensely with CD1b tetramers, it was
the weakest responder in terms of CD69 up-regulation in three
independent experiments. Altogether, these data prove that we
have identified three Vδ1 γδ TCRs that bind CD1b directly and can
initiate signaling.
Key CD1b Residues for γδ TCR Binding. To begin to consider how γδ
TCRs might bind CD1b, we first considered where four known
CD1b-specific αβ TCRs map onto the antigen display platform
formed by the α1 and α2 helices of CD1b. When bound to MHC
proteins, peptide antigens span nearly the entire width of the
display platform. In contrast, CD1b has a portal where lipid an-
tigens emerge, whereas the remainder of the CD1b antigen display
platform is a closed structure known as the roof (28–31). To de-
termine which residues that form the CD1b antigen display plat-
form are important for binding of γδ T cells, based on the CD1b
crystal structure, we generated 14 mutant CD1b-endo tetramers
and tested staining of J76.BC14.1, J76.BC14.2, and J76.BC14.4
clones. Alanine-substituted residues were surface-exposed resi-
dues in the α1 helix (K61A, E65A, E68A, I69A, V72A, E80A,
D83A) or the α2 helix (Y151A, Q152A, E156A, R159A, I160A,
E164A, T165A) and, as such, were considered not to impact lipid
antigen display (Fig. 3A). As a reference value we used unmutated
wild-type (WT) CD1b made in the same system. As a positive
control we used WT CD1b from the NIH tetramer facility, which
allowed us to determine a fraction of positively staining cells for
each tetramer (Fig. 3B).
Given the nonpolymorphic nature of CD1b and the conserved
use of Vδ1, we hypothesized the existence of a conserved mode of
CD1b recognition. However, staining patterns of CD1b tetramer-
positive cells across all mutants were clearly different for each of
the three Vδ1 TCRs, and the results were highly reproducible in
two independent experiments (Fig. 3C and SI Appendix, Fig. S4).
For BC14.1 none of the tested mutant CD1b tetramers affected
tetramer binding. For BC14.4 strong effects of E80A and D83A
mutations on tetramer binding were observed, but not of other
residues. Binding to BC14.2 was reduced by mutations K61A,
E68A, I69A, V72A, E80A, D83A, Q152A, E156A, and R159A.
Every mutant CD1b tetramer stained at least one of the Jurkat 76
clones, demonstrating that none of the used mutant tetramers
failed to fold or was otherwise functionally defective. Therefore,
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the differing patterns were encoded in the TCRs. These studies
demonstrate that the footprints of these three TCRs on CD1b are
markedly different from each other, ranging from an extensive
area of CD1b that interacts with the BC14.2 TCR to no effect of
any of the 14 mutants spread throughout the CD1b antigen display
platform on binding to the BC14.1. The latter observation suggests
a docking mode that is very different from known CD1b-αβ TCR
interactions, which bind the antigen display platform of CD1b.
Affinity of the BC14.1 TCR toward CD1 Molecules. In surface plas-
mon resonance (SPR) assays, CD1b and CD1c loaded with en-
dogenous lipids were coupled to the sensor surface, with BC14.1
TCR used as an analyte (Fig. 3D). The steady state dissociation
constant (KD) of the BC14.1 TCR bound to CD1b was ∼9.5KD ±
0.54, which represents a high-affinity interaction, and exhibited
no cross-reactivity to CD1c. Notably, the BC14.1 TCR bound
CD1b with a higher affinity than the BC8 TCR and represents a
slightly higher affinity interaction than the low to middle mi-
cromolar interactions obtained for other MHC-like molecules
such as CD1c (18), CD1d (20), and MR1 (15).
γδ TCR Specificity for Lipids Presented by CD1b. Antigens insert their
alkyl chains into CD1b to position their hydrophilic head groups
on the outside of CD1b for TCR contact. Some CD1-autoreactive
TCRs bind on the closed roof of CD1 proteins and so are not
dependent on the bound lipid (34, 35). However, large head groups
on “nonpermissive ligands” tend to block these CD1–TCR in-
teractions, whereas smaller head groups on “permissive ligands”
permit CD1–TCR interactions. The BC14.2 TCR footprint on the
CD1b antigen display platform surrounds the antigen portal
through which antigens normally protrude to the surface of CD1b
(Fig. 3C). Therefore, binding of this TCR is predicted to be af-
fected by the type of lipid carried in the CD1b cleft. To test this, we
determined the pattern of lipid reactivity of γδ TCRs by staining
them with a panel of CD1b tetramers treated with common self-
glycerophospholipids or sphingolipids or the bacterial lipids phos-
phatidylinositol dimannoside (PIM2) and diacyltrehalose (DAT).
This panel included lipids with known CD1b-binding properties
whose head groups ranged from small to large, containing one,
two, or more carbohydrates (Fig. 4A) (29). Staining of cell lines
expressing the HD1B and PG90 TCRs, two CD1b-specific αβ
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Fig. 2. Tetramer-positive γδ T cells are autoreactive to CD1b. (A) IFN-γ ELISPOT of line TS1+ stimulated with K562.CD1a or K562.CD1b cells in the absence of
exogenously added antigen. Error bars represent the SEM of triplicate wells. One representative experiment of three is shown. (B) Flow cytometry dot plots of
line TS1+ after coculture with CD1a- or CD1b-expressing K562 or C1R cells. One representative experiment of three is shown. (C) Flow cytometry histograms
show changes in cell surface levels of Vδ1, CD3, CD25, and CD69 on CD1b tetramer+CD3+ cells after stimulation by C1R.CD1a or C1R.CD1b cells for 20 h. (D)
Flow cytometry histograms show 293T cells transfected with γδ TCRs and CD3 complex proteins stained with CD1b tetramers. The mean fluorescence intensity
(MFI) of the CD1b tetramer is shown for GFP-negative and GFP-positive 293T cells. (E) Flow cytometry dot plots and histograms of J76 cells stably transduced
with γδ TCRs. (F) Flow cytometry dot plots of J76 cell lines after stimulation by C1R.CD1a or C1R.CD1b cells for 20 h. One representative experiment of three
experiments is shown.
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TCRs with known lipid reactivity patterns (27, 29, 30), was in-
cluded as a positive control for tetramer loading with lysophos-
phatidic acid, phosphatidylglycerol (PG), and phosphatidylserine
(PS) (SI Appendix, Fig. S5). Both J76.BC14.1 and J76.BC14.4
recognized CD1b treated with a broad range of lipids, including
phospholipids and sphingolipids, while J76.BC14.2 strongly rec-
ognized phosphatidylinositol (PI) and, to a lesser extent, phos-
phatidylethanolamine (PE), phosphatidylcholine (PC), and DAT
(Fig. 4B). Thus, the BC14.2 TCR is an antigen-specific TCR.
BC14.4 is influenced by the loaded lipid but has much less
stringent requirements for the lipid that is present in the CD1b
groove, and BC14.1 shows no detectable signs of sensitivity to
lipid ligands in CD1b. Unlike all other CD1-reactive TCRs that
we know of, BC14.1 recognition is not influenced by 14 CD1b
antigen display platform residues, nor does the lipid that is
bound by CD1b contribute to the specificity of the TCR, sug-
gesting docking at the extreme end or the sides of the α1 and α2
helices or the α3 domain of CD1b or β2M.
Dual Specificity of the BC14.1 TCR. Even though we have firmly
established the specificity of the BC14.1 TCR for CD1b, other
Vγ4Vδ1 cells have been reported to respond to cells cotrans-
duced with human BTNL3 and BTNL8 (8). The hypervariable
region 4 (HV4) domain of Vγ4 is essential for interaction with
the BTNL3 and BTNL8 heterodimer (BTNL3+8) and may act
independently of the clonally rearranged parts of the TCR, such
as the CDR3γ and the CDR3δ (9, 10). To investigate whether
this BTNL responsiveness also applies to the BC14.1 Vγ4Vδ1
TCR, we cocultured the TCR-transduced Jurkat cell lines with
K562 cells expressing BTNL3+8 (K562.EV or K562.CD1b with
or without BTNL3+8, SI Appendix, Fig. S6). We observed only
minor CD69 up-regulation on J76.BC14.1 cells when stimulated
with K562.CD1b cells (Fig. 5A), as expected based on results
with C1R.CD1b stimulation (Fig. 2F). However, when stimu-
lated with K562.EV.BTNL3+8, J67.BC14.1 cells strongly up-
regulated CD69 (Fig. 5A). The percentage of CD69 positive
J76.BC14.1 cells after stimulation with K562.CD1b.BTNL3+8
was similar to the expression observed after stimulation with the
K562.EV.BTNL3+8-stimulated cells. As expected based on their
lack of expression of a Vγ4 chain, both J76.BC14.2 and J76.BC14.4
cell lines showed CD69 up-regulation when stimulated with K562
cells expressing CD1b, regardless of the coexpression of BTNL3+8
(Fig. 5A). Melandri et al. recently proposed dual recognition of
CD1c and butyrophilins or EPCR and butyrophilins by human
Vγ4+ TCRs (9), and these studies confirm this model and extend it
to CD1b.
Specificity for CD1b Is Mediated by the δ Chain.No additional effect
of CD1b was observed when J76.BC14.1 was stimulated with
K562 cells expressing both CD1b and BTNL3+8. This observa-
tion raised the question of whether BTNL3+8 creates maximal
binding such that effects of CD1b are present but not additive or
whether BTNL3+8 and CD1b compete for binding to the TCR.
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J76.BC14.4 were tested for binding of CD1b-endo tetramers with the indi-
cated point mutations by flow cytometry (representative dot plots in B;
complete data set in SI Appendix, Fig. S4) summarized in bar graphs showing
fold change in staining compared to wild-type CD1b-endo produced using
the same platform (C, Left). Representation of the CD1b surface (white),
with residues that affect tetramer binding when mutated to alanine sub-
stantially (red, greater than fourfold reduction) or moderately (orange,
twofold to fourfold reduction) (C, Right). Light and dark gray bars show two
independent experiments per mutant tetramer. WT: wild-type CD1b tetra-
mer from the NIH tetramer facility. (D) Representative SPR sensorgrams (Left
and Middle) and derived steady-state affinity measurements (Right) of the
BC14.1 TCR (Top) and control TCR BC8 (Bottom) against endogenously
loaded CD1b and CD1c. Two independent SPR experiments were conducted,
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A first step toward answering this would be to determine which
parts of the BC14.1 TCR interact with CD1b. Whereas the genome-
encoded part of Vγ4 was previously demonstrated to interact with
BTNL3-BTNL8, CDR3 regions almost always contribute to rec-
ognition of antigenic targets. To test whether the CDR3γ of BC14.1
was necessary for CD1b binding, we transfected 293T cells with a
modified version of the BC14.1 TCR in which the native Vγ4 chain
was replaced by a Vγ4 chain from the CD1d-specific γδ TCR
DP10.7 (17). This TCR has a different CDR3γ, while the BC14.1
Vδ1 chain remained unchanged. Expression of modified TCRs by
the 293T cells was confirmed by anti-CD3 and anti-γδ TCR staining
(Fig. 5 B, Upper). We observed that when stained with CD1b-endo
tetramers, the TCR using BC14.1 Vδ1 combined with a different
Vγ4 chain was still able to bind the tetramer at a level comparable
to the wild-type receptor, whereas nontransfected cells did not bind
the tetramer (Fig. 5 B, Lower, first three plots). Thus, the CDR3γ of
BC14.1 is not required for recognition of CD1b.
Replacement of the Vγ4 chain of BC14.1 with the DP10.7
TCR Vγ4 chain changes the CDR3γ but not the CDR1γ and
CDR2γ loops. To assess whether the CDR1γ or CDR2γ loops or
other genome-encoded parts of Vγ4 contribute to CD1b binding,
we transfected and stained 293T cells with additional modified
BC14.1 TCRs. These TCRs consist of the BC14.1 Vδ1 chain
combined with representatives of all functional human γ chains:
Vγ2, Vγ3, Vγ5, Vγ8, and Vγ9, which we selected from CD1c- and
CD1d-specific γδ T cells (SI Appendix, Table S1). These modified
TCRs expressed well on the surface of 293T cells (Fig. 5C).
Replacing the Vγ4 chain with Vγ2, Vγ3, Vγ5, and Vγ8 did not
cause loss of CD1b tetramer binding. However, replacement with
a Vγ9 chain completely abrogated binding of CD1b by the TCR
(Fig. 5C). Based on sequence comparisons, TRGV9 is quite dis-
tinct from the other Vγ segments, so loss of CD1b binding could
not be assigned to the CDR1γ and CDR2γ loops or any other
specific part of the sequence (SI Appendix, Fig. S7). When com-
paring TRGV2, TRGV3, TRGV5, and TRGV8, the high vari-
ability in CDR1γ and CDR2γ loop sequences contrasts with their
uniform support of CD1b binding and suggests that CDR1γ and
CDR2γ are not determinative of CD1b binding. However, the
CDR1γ and CDR2γ loops of these TRGV genes do share some
residues that are not present in TRGV9, including amino acids Y
at the end of CDR1γ and YD at the beginning of CDR2γ.
Therefore, involvement of the CDR1γ and CDR2γ loops cannot
be completely ruled out. However, because the Vγ4 chain does
not seem to play a major role in binding of CD1b, it is extremely
unlikely that the binding sites of the BTNL3+BTNL8 hetero-
dimer and CD1b overlap.
Our results also suggest that the CD1b specificity of BC14.1 is
mostly determined by its Vδ1 chain. To test whether the CDR3δ
or other parts of the δ chain direct binding of CD1b, we trans-
fected 293T cells with a modified version of BC14.1 where we
preserved the γ chain and combined it with a Vδ1 chain with a
different CDR3δ, from the T cell line CO3. The cells expressing
the altered TCR did not bind the CD1b-endo tetramer but were
expressed at the surface (Fig. 5B). Thus, CD1b specificity of BC14.1
is dominated by the CDR3δ. Other parts of the TCR may con-
tribute to CD1b binding but are not sufficient for binding without
the correct CDR3δ. This situation is reminiscent of the G8 γδ
TCR where CDR3δ dominates the recognition of the murine T22
molecule (36).
Discussion
Here we describe recognition of the antigen-presenting molecule
CD1b by human γδ T cells. CD1b-specific γδ T cells were found
at low frequency in the blood of all donors tested and were acti-
vated by stimulation with CD1b. CD1b tetramer staining of TCR-
transduced cells formally ruled in γδ TCRs as CD1b ligands.
These findings contribute to the understanding that members of
the human CD1 protein family function as natural targets for Vδ1
T cells. Recognition of CD1b likely has functional parallels with
recognition of CD1c and CD1d. However, unlike CD1c and
CD1d, which are constitutively expressed in the periphery, CD1b
has a unique pattern of activation-induced expression on myeloid
cells (22, 26, 37). Also, CD1b has a larger antigen-binding cleft
that is suitable for lipid antigens that cannot fit within CD1c and
CD1d.
Further, the particular patterns of TCR-mediated recognition
of CD1b and BTNLs shown here provide insights into how γδ
TCRs approach and recognize their targets. The expansion of di-
verse, antigen-specific γδ T cell clones upon exposure to pathogens
like cytomegalovirus, Epstein–Barr virus, and herpes simplex virus is
a prime example of how γδ T cells take part in adaptive immune
responses (38–43). On the other hand, semi-invariant γδ T cell
populations that are present in large numbers in all individuals of
a species, such as dendritic epidermal γδ T cells in mice and the
Vγ9Vδ2 T cell population in humans, seem to play a role in
innate-like tissue surveillance. These semi-invariant populations
can exert rapid responses without the need for clonal expansion
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and differentiation (44, 45). In discussing three CD1b-reactive γδ
TCRs, we emphasize the question of whether their targets are
constitutively expressed molecules, consistent with a role in ho-
meostatic survival; molecules regulated by stress or inflamma-
tion, consistent with a role in innate immunity; or complexes of
antigen-presenting molecules and lipids, consistent with a role in
adaptive immunity.
All known αβ T cells (28–31) dock on the CD1b antigen dis-
play platform, where they bind near or over the antigen portal.
Because the Vδ1 frequency was increased among CD1b tetra-
mer+ cells and CD1b is nonpolymorphic, Vδ1 might be part of a
TCR pattern that binds CD1b with a conserved docking mode.
Unexpectedly, we found a unique footprint for each of the three
tested γδ TCRs. BC14.2 and BC14.4 TCR binding is influenced
by treating CD1b with lipid ligands and is lost after alanine
substitutions close to the antigen portal of CD1b, indicating that
lipid sensing by these two Vδ1 TCRs likely occurs through TCR
contact with lipid as it protrudes from the antigen portal. BC14.2
TCR binding is lost after mutation of any of nine residues lo-
cated on either side of the antigen exit portal. In contrast the
BC14.4 TCR requires E80 and E83, which are located on the
right side of the portal. These findings suggest a footprint on the
CD1b antigen display platform in the vicinity of the antigen
portal. Thus, these TCRs use different approaches from CD1b,
but both recognize antigens, supporting the idea that γδ TCRs
recognize distinct combinations of CD1b and lipid.
Binding by the BC14.1 TCR is different, as we could not es-
tablish a footprint on the antigen display platform of CD1b with
the mutant tetramers tested. After our studies were completed, a
new mode of ligand binding by γδ TCRs was published, chal-
lenging the general view on how TCRs bind antigen-presenting
molecules. Instead of binding the membrane-distal surface, the
antigen display platform, of MR1, a γδ TCR was shown to bind
the platform “down under,” contacting the α3 domain (15). It is
possible that TCR recognition of antigen-presenting molecules
at locations other than the top surface of the antigen display
platform is more common than previously thought, and the CD1b-
BC14.1 interaction might be the second example. Attempts at
crystallization have not succeeded, so structural proof is lacking. It
is notable that for the 12 lipid ligands tested, nearly all of which
affect other TCRs, none affected BC14.1 binding to CD1b. This
outcome independently suggests TCR binding at a site distant from
the antigen portal, which is readily explained by the proposed
down-under binding mechanism. Whatever the point of contact,
the lipid-independent recognition of an immune-inducible protein
like CD1b is consistent with the TCR behaving as a receptor to
amplify innate inflammation, like members of the immunoglobulin-
like transcript (ILT) family of receptors recognizing CD1c and
CD1d (46–49).
The discovery of γδ TCR recognition of the constitutively
expressed BTNL family of proteins provides a candidate expla-
nation for the selection and maintenance of γδ TCRs (9, 10). The
human TRGV4 segment in Vγ4+ TCRs mediates the recognition
heterodimer of BTNL3 and BTNL8. More specifically, the evo-
lutionally conserved hypervariable region 4 (HV4) motif of the
Vγ4 chain is essential (9, 10). Recognition of BTNL3+8 hetero-
dimers by Vγ4+ T cells is considered innate since the HV4 region
is germ line encoded, and BTNLs do not present antigens. In-
spired by this, we wanted to know if BC14.1, which also uses
TRGV4, recognizes BTNL3+8. In addition to CD1b, Jurkat cells
expressing the Vγ4+ TCR BC14.1 also recognized BTNL3+8. In
fact, BTNL3+8 was a stronger stimulus for these cells than CD1b.
Melandri et al. proposed that the γ chain HV4 mediates recog-
nition of BTNLs and other parts of the TCR, including the
rearranged CDR3s, contact CD1d-lipid or CD1c-lipid, and inter-
preted these interactions as innate and adaptive recognition
modes by one TCR, respectively (9). Our findings show that rec-
ognition of CD1b is mediated by an adaptive, rearranged part of
the BC14.1 TCR, but the antigen-presenting capacity of CD1b is
ignored and redundant. Binding of CD1b by BC14.1 is dominated
by the Vδ1 chain, leaving the Vγ4 accessible for binding of
BTNL3+8. Our data raise the possibility that simultaneous en-
gagement of CD1b and BTNL by γδ T cells might be possible.
Thus, in addition to being a bona fide antigen-presenting
molecule, the mere presence of CD1b, regardless of the bound
lipid, can stimulate certain γδ T cells. This strongly supports a
physiologic role for regulation of surface expression of CD1b in
immune responses. CD1b is up-regulated during inflammation-
induced monocyte differentiation, via GM-CSF, IL-4, and IL-1β
(23–25), which in turn can promote the activation of γδ T cells,
such as BC14.1, that take part in innate stress surveillance.
Materials and Methods
Recombinant Proteins and Tetramers. For lipid loading, WT CD1b monomers
were obtained from the NIH tetramer facility. In a 10 mm wide glass tube,
16 μg of dry lipid were sonicated at 37 °C for 1 h in 45 μL of 0.5% 3-[(3-
cholamidopropyl)dimethylammonio]-1-propanesulfonate in 50 mM sodium
citrate buffer (pH 4.5) for DAT or 45 μL of 0.5% CHAPS 50 mM sodium citrate
buffer (pH 7.4) for other lipids. Subsequently, CD1b monomers (10 μg) were
added to the tubes and incubated overnight at 37 °C. The next day the
solution for DAT-loaded monomers was neutralized to pH 7.4 by adding 5 μL
1M Tris (pH 8). Mutant monomers were generated as described and used
without treatment with exogenous lipids (28). CD1b was expressed in
HEK293S GnTI cells (from ATCC). Alanine mutants of the CD1b molecules
were generated by site-directed mutagenesis and expressed in mammalian
cells under equivalent conditions used to produce the WT CD1b molecule.
Monomers were tetramerized using streptavidin-APC (Molecular Probes) or
streptavidin-PE (Invitrogen). For WT CD1b-endo, mutant CD1b-endo, CD1a-
endo, CD1c-endo, and CD1d-endo tetramers the monomers were diluted in
Tris-buffered saline (0.2 mg/mL) and tetramerized.
Lipids. PC (#850475; C18:1/C16:0), sphingomyelin (#860584; C18:1/C16:0), PI
(#840042; mixture from bovine liver with a range of fatty acids), PS (#840032;
mixture from porcine brain with a range of fatty acids), phosphatidic acid (PA,
#840857; C18:1/C16:0), lyso-PA (#857130; C18:1), PE (#850757; C18:1/C16:0),
and PG (#840503; C18:1/C18:0) were purchased from Avanti polar lipids.
Gangliosides GM1 (G7641; mixture from bovine brain with a range of fatty
acids) and GM2 (G8397; mixture from bovine brain with a range of fatty
acids) were purchased from Sigma. PIM2 and DAT, previously described as
DAT2a, were provided by the Bill and Melinda Gates Foundation lipid bank.
Staining Protocol. Human PBMCs, T cell lines, and Jurkat lines were stained
with tetramers at 2 μg/mL in phosphate-buffered saline (PBS) containing 1%
bovine serum albumin and 0.01% sodium azide. Cells and tetramers were
incubated for 10 min at room temperature, followed by the addition of
antibodies and another incubation for 10 min at room temperature, fol-
lowed by 20 min at 4 °C. Cells were analyzed using the BD LSRFortessa flow
cytometer and FlowJo software. Antibodies that were used are as follows:
CD3-BV421 (UCHT1; Biolegend), CD3-FITC (SK7; BD Bioscience), γδTCR-PE (B1;
Biolegend), αβTCR-APC (IP26; Biolegend), Vδ1-FITC (TS-1; Invitrogen), Vδ2-PE
(B6; Biolegend), CD25-PE (BC96; Biolegend), CD69-PE (FN50; Biolegend),
CD69-APC (FN50; Biolegend), CD1b-PE (SN13/K5-1B8; Ancell), DYKDDDDK
Tag-BV421 (Flag tag, L5; Biolegend), and HA-APC (16B12; Biolegend).
T Cells and T Cell Lines. PBMCs were obtained from leukoreduction collars
provided by the Brigham andWomen’s Hospital Specimen Bank, as approved
by the Partners Healthcare Institutional Review Board, and cultured over-
night in medium containing 0.2 ng/mL IL-15 before staining. γδ T cells were
enriched using the untouched TCRγ/δ + T cell isolation kit (Miltenyi Biotec).
Cells were analyzed using the BD LSRFortessa flow cytometer and FlowJo
software. For generation of T cell lines, total PBMCs or PBMC-derived T cells
were stained with CD1b-DAT tetramer and anti-CD3. PBMCs were sorted for
double positive staining of CD3 and tetramer. Expansion of sorted cells was
performed by plating cells at 100 to 700 cells/well in round-bottom 96-well
plates containing 2.5 × 105 irradiated allogeneic PBMCs, 5 × 104 irradiated
Epstein–Barr virus transformed B cells, and 30 ng/mL anti-CD3 antibody
(clone OKT3) per plate. The next day human IL-2 or a mix of human IL-2, IL-7,
and IL-15 was added to the wells. After 2 wk, the sorting and expansion
procedure was repeated as needed.
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γδ TCR Sequencing and Transient Transfection. TCR sequences were deter-
mined by isolating RNA from bulk sorted γδ T cell populations using the
RNeasy kit (QIAGEN), followed by cDNA synthesis using the QuantiTect Re-
verse Transcription Kit (QIAGEN). TCRγδ transcripts were amplified using a
multiplex approach (50), followed by direct Sanger sequencing of the PCR
product. Full-length TCR γ and TCR δ chains separated by self-cleaving 2A
peptide were purchased from GENEWIZ and cloned into a (MSCV)-IRES-GFP
(pMIG) vector. All plasmids used for transfection were purified using a QIAprep
Spin Miniprep Kit (QIAGEN) or NucleoBond Xtra Midi EF kit (Macherey-Nagel).
HEK293T cells were cotransfected with pMIG-TCR and pMIG-CD3δγeζ using
FuGENE-6 (Promega) (51). Expression of TCR and CD3 and binding of tetramer
were analyzed using the BD LSRFortessa flow cytometer and FlowJo software.
For replacement of TCR γ chains, full-length TCRγ gene segments were pur-
chased from GENEWIZ and used to replace the γ chain of the BC14.1 TCR in the
(MSCV)-IRES-GFP (pMIG) using EcoRI and BspEI.
Transduction of Jurkat 76 Cells with TCR and K562 Cells with BTNL. pMIG-TCR
and pMIG-CD3δγeζ were cotransfected into HEK293T cells in the presence of
the retroviral packaging vectors pPAM-E and pVSV-g. Medium was replaced
16 h after transfection. Supernatant containing virus was collected at 48 h
and filtered through 0.45 μm nylon mesh, followed by concentration of virus
using a Mag4C-LV kit (OZ Biosciences). Concentrated virus was used to stably
transduce TCR-deficient Jurkat clone 76 cells (33) to generate the BC14 T cell
lines. After 5 d, cells with the highest expression of TCR, GFP, and CD3 were
single-cell sorted using the BD FACSAria. K562.EV and K562.CD1b cell lines
were transduced with FLAG-BTNL3 and HA-BTNL8 cloned into pCSIGPW (9).
Cells with the highest expression of GFP and BTNL3 (anti-Flag staining) or
BTNL8 (anti-HA staining) were single-cell sorted and expanded.
Functional T Cell Assays. For enzyme-linked immune absorbent spot (ELISPOT)
assays, cocultures of 2 × 104 APCs and 3 × 103 T cells were incubated for 16 h
in a Multiscreen-IP filter plate (96 wells; Millipore) coated according to the
manufacturer’s instructions (Mabtech). For coculture assays, T cell lines and
Jurkat cell lines were cultured with C1R or K562 cells (1:2) overnight in
round-bottom 96-well plates, and their activation status was measured by
flow cytometry to detect TCR down-regulation and IL2R and CD69 up-
regulation for T cells and CD69 up-regulation for Jurkat cell lines.
CRISPR/Cas9 Editing of Jurkat 76 Cells. CRISPR/Cas9 ribonuclear protein (RNP)
complexes were assembled as previously described (52). In short, 40 μM Cas9
protein (QB3 Mircolabs) was mixed with equal volumes of 40 μM modified
single guide (sg)RNA targeting CD1B (Synthego; targets: rs158331053,
rs158331042, rs158331007, rs158330955) and incubated at 37 °C for 15 min
to form RNP complexes. Jurkat 76 cells were nucleofected with RNPs in an
Amaxa 4D nucleofector (SE protocol: CL-120). Cells were immediately transferred
to 24-well plates with prewarmed media and cultured. After 7 to 10 d, CD1b
expression was assessed by flow cytometry, and cells were single-cell sorted
based on the absence of CD1b staining. Editing of clonal cell lines was confirmed
by PCR amplifying and sequencing genomic DNA around CD1b, and sequences
were analyzed by Tracking of Indels by Decomposition (TIDE) analysis (tide.nki.nl).
Recombinant Proteins and Surface Plasmon Resonance. Recombinant BC14.1
γδ TCR chimeras were cloned into the pET30a vector utilizing the α and β
constant domains, expressed, refolded, and purified from Escherichia coli inclu-
sion bodies. Inclusion bodies were resuspended in 6 M guanidine hydrochloride,
20 mM Tris·HCl (pH 8.0), 0.5 mM sodium-ethylenediaminetetraacetic acid, and
1 mM dithiothreitol. The TCR was refolded by rapid dilution into 3 M urea,
100 mM Tris (pH 8.5), 2 mM Na-EDTA, 400 mM L-arginine-HCl, 0.5 mM oxidized
glutathione, 5 mM reduced glutathione, and 1mM phenylmethylsulfonyl fluo-
ride. The refolding solution was then dialyzed into 20 mM Tris·HCl (pH 8.5). The
refolded protein was purified via diethylethanolamine anion exchange and
further purified by size exclusion chromatography. Soluble CD1b was expressed
using HEK293 S GnTI− (American Type Culture Collection) cultured in Dulbecco’s
Modified Eagle Medium supplemented with 10% (vol/vol) fetal calf serum.
Media containing soluble CD1b was dialyzed extensively into 20 mM Tris·HCl (pH
8.0) and 150 mM NaCl and purified by HisTrap nickel nitrilotriacetic acid-affinity
chromatography and further purified via size exclusion chromatography (29).
SPR experiments were conducted at 25 °C on a BIAcore 3000 instrument in
20 mM Tris (pH 8.0) and 150 mM NaCl supplemented with 0.5% (wt/vol) BSA.
CD1 proteins were captured on a streptavidin-coated SA sensor chip (GE
Healthcare), where ∼1,500 response units of endogenously loaded CD1b or
CD1c were immobilized. Serial dilutions from 100 to 0 μM of BC14.1 TCR and
the BC8 TCR control were injected over the immobilized CD1 proteins at a flow
rate of 5 μL min−1. All experiments were performed in duplicate with an in-
dependent experimental replicate conducted again in duplicate. The sensor-
gram plots and kinetic parameters were calculated in Prism using a one-site
Langmuir binding model.
Data Availability. All study data are included in the article and SI Appendix.
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